Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Insulet's Programs at the American Association of Diabetes Educators Conference and Its New San Diego Innovation Center of Excellence Highlight Company's Commitment to Innovation
Insulet to Host Three Educational Events at the AADE Conference in Indianapolis BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System (Omnipod System), today
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conferences
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City , New York : This
View HTML
Toggle Summary Insulet to Assume Distribution and Commercial Support for Its Omnipod® System in Europe
Direct Distribution Supports Strong and Growing European Customer Base Further Strengthens Company's Financial Outlook BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin
View HTML
Toggle Summary Insulet Corporation to Announce Second Quarter 2017 Financial Results on August 3, 2017
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2017 on August 3, 2017
View HTML
Toggle Summary Insulet Presents Positive Omnipod® Horizon™ Hybrid Closed-Loop Study Results in Children
Strong results show potential for Horizon to improve clinical outcomes in pediatric and adolescent age groups with type 1 diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet to Preview New Clinical Data and Next Generation Omnipod® System at the American Diabetes Association's 77th Scientific Sessions
Company Further Demonstrates Significant Impact on Improving the Quality of Life of People with Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin Management System
View HTML
Toggle Summary Insulet Corporation to Present at Upcoming Investor Conference
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on
View HTML
Toggle Summary Beyond Type 1's CrossCountry "Bike Beyond" Program To Kick Off On June 3rd, 2017
Toggle Summary Insulet Appoints Bret Christensen as Chief Commercial Officer
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced the appointment of Bret Christensen as Chief Commercial Officer. Mr.
View HTML
Toggle Summary Insulet Corporation Ranked #4 on Forbes 2017 Most Innovative Growth Companies List
Leader in Tubeless Insulin Pump Technology Ranks in Top Five Percent Among List of Most Innovative 100 Public Companies BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®  Insulin
View HTML
Toggle Summary Insulet Reports First Quarter 2017 Financial Results
First Quarter Revenue of $101.7 Million , up 25% Year-Over-Year, Exceeds Expectations Gross Margin Improves to 58.4% Insulet Raises Mid-Point of Full Year 2017 Revenue Guidance, Expecting Growth of 18%, and Introduces Second Quarter Growth Expectation of 21% BILLERICA, Mass.
View HTML
Toggle Summary Insulet Corporation to Announce First Quarter 2017 Financial Results on May 8, 2017
BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the first quarter 2017 on May 8, 2017 after the
View HTML
Toggle Summary Insulet Reports Fourth Quarter and Full Year 2016 Financial Results
Fourth Quarter Revenue of $103.6 Million , up 24% Year-Over-Year; Full Year 2016 Revenue of $367.0 Million , up 39% Year-Over Year, Exceeds Expectations Fourth Quarter Gross Margin Improves to 58.8%; Full Year 2016 Gross Margin Improves to 57.5% Insulet Expects Full Year 2017 Revenue Growth of
View HTML
Toggle Summary Insulet Presents Strong Omnipod® Horizon™ Hybrid Closed-Loop Study Results at ATTD in Paris
First Feasibility Study on the Automated Glucose Control Algorithm Demonstrates Beneficial Results in Adults with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation  (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ®
View HTML
Toggle Summary Insulet Completes Acquisition of U.S. Manufacturing Facility in Acton, Massachusetts
Facility to Support Long-Term Growth Initiatives While Driving Increased Productivity and Quality BILLERICA, Mass. --(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today
View HTML